Danaher (DHR)
(Delayed Data from NYSE)
$275.19 USD
+3.54 (1.30%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $273.89 -1.30 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$275.19 USD
+3.54 (1.30%)
Updated Jul 30, 2024 04:00 PM ET
After-Market: $273.89 -1.30 (-0.47%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
General Electric (GE) Beats Q2 Earnings Estimates, Hikes View
by Zacks Equity Research
General Electric's (GE) Q2 earnings reflect gains from healthy sales performance in the Industrial segment, cost reduction and improved margin. It increases the free cash flow projection for 2021.
Danaher (DHR) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Analyst Blog Highlights: Apple, Danaher, Novartis, AT&T and Estee Lauder
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, Danaher, Novartis, AT&T and Estee Lauder
Top Stock Reports for Apple, Danaher & Novartis
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Danaher (DHR), and Novartis (NVS).
Danaher (DHR) Beats on Q2 Earnings, Ups 2021 Core Sales View
by Zacks Equity Research
Danaher's (DHR) Q2 results reflect strength in segmental businesses, the impact of pandemic-led tailwinds and improved margins. Projection for core sales growth, including Cytiva, increases for 2021.
Danaher (DHR) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 20.59% and 7.83%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
5 Hottest Earnings Charts This Week
by Tracey Ryniec
These companies have earnings surprise track records and charts to envy.
Here's Why You Should Invest in Water ETFs
by Neena Mishra
Water sustainability is a growing concern for many investors
FSS vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FSS vs. DHR: Which Stock Is the Better Value Option?
Carlisle (CSL) to Buy Henry, To Boost Construction Business
by Zacks Equity Research
Carlisle's (CSL) Henry buyout is likely to strengthen its growth prospects in North America residential and commercial construction markets. Henry will be added to the Carlisle Construction Materials segment.
Danaher (DHR) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Danaher (DHR) Q2 performance is likely to have gained from the pandemic-induced demand for products, focus on innovation and synergistic gains from acquired assets.
Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Much You'd Have If You Invested $1000 in Danaher a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Can Danaher (DHR) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
If You Invested $1000 in Danaher a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Here's How Investors Can Find Strong Multi-Sector Conglomerates Stocks with the Zacks ESP Screener
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
5 Stocks to Ride High in Booming Diversified Operations Industry
by Payal Jalan
Healthy pandemic-led demand and improving manufacturing activities are benefitting players in the Zacks Diversified Operations industry. DHR, CSL, ITT, CR and GFF are stocks with earnings potential.
Danaher's (DHR) Aldevron Buyout to Aid Genomic Medicine
by Zacks Equity Research
Danaher (DHR) to gain from the Aldevron acquisition as it will increase growth opportunities in the genomic medicine field. The acquired assets will be integrated with Danaher's Life Sciences segment.
The Zacks Analyst Blog Highlights: Target, NVIDIA, The Sherwin-Williams Co, Danaher Corp and FedEx
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Target, NVIDIA, The Sherwin-Williams Co, Danaher Corp and FedEx
Danaher (DHR) Moves 5% Higher: Will This Strength Last?
by Zacks Equity Research
Danaher (DHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Time to Focus on Danaher (DHR) for Strong Earnings Growth Potential
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Danaher (DHR).
5 Picks as Inflation is Transitory and Tapering Is Not in View
by Nalak Das
We have narrowed down our search to five corporate bigwigs that have provided better returns than the S&P 500 Index in the past three months. These are: FDX, SHW, DHR, TGt and NVDA.
Here's Why it is Worth Investing in Griffon (GFF) Stock Now
by Zacks Equity Research
Griffon (GFF) is likely to benefit from favorable macro trends, solid product offerings, well diversified business structure, sound manufacturing capacity, buyouts & shareholder-friendly policies.
Zacks.com featured highlights include: 1-800-FLOWERS.COM, Polaris, The Sherwin-Williams Co, Danaher Corp and Navient Corp
by Zacks Equity Research
Zacks.com featured highlights include: 1-800-FLOWERS.COM, Polaris, The Sherwin-Williams Co, Danaher Corp and Navient Corp
5 of the Best Stocks to Invest in for Superb Earnings Growth
by Tirthankar Chakraborty
1800 FLOWERS.COM (FLWS), Polaris (PII) & Danaher (DHR) are some of the top stocks that have striking earnings growth and positive estimate revisions at present.